Video

Studying the Benefits of Monotherapy and Combined Therapies in Diabetes

Author(s):

As the diabetes epidemic continues there are always new treatments being developed. For doctors treating the condition there are many questions to be answered including which therapies work best for their individual patients

%jwplayer%

As the diabetes epidemic continues there are always new treatments being developed. For doctors treating the condition there are many questions to be answered including which therapies work best for their individual patients

At the annual meeting of the American Diabetes Association in New Orleans, Peter P. Stein, MD, from Merck, discussed some of the results his company presented at the meeting showing how their therapy options have helped patients in a variety of areas. While for some patients diet and exercise are sufficient, Stein said some patients are able to have better control with only one medication while others showed better results with a combination of different therapies without significant safety concerns.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Viet Le, DMSc, PA-C | Credit: APAC
© 2025 MJH Life Sciences

All rights reserved.